NCT06440629 2026-02-05
RA-DRUM
Diakonhjemmet Hospital
Phase 4 Recruiting
Clinical Trials
13 trialsNCT06833112 2025-02-18
Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis
The Affiliated Hospital Of Guizhou Medical University
Phase 4 Not yet recruiting
NCT04646187 2025-01-06
FREE
University Medical Center Groningen
Phase 4 Enrolling by invitation
NCT01793519 2024-02-28
STARA
Georgetown University
Phase 4 Unknown
NCT04255134 2023-05-18
BIORA-PAIN
St George's, University of London
Phase 4 Completed
NCT00837434 2021-09-22
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 4 Completed
NCT02092467 2021-08-17
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Pfizer
Phase 4 Completed
NCT02492217 2020-11-03
Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients
Universidade Nova de Lisboa
Phase 4 Completed
NCT00932113 2017-08-31
MOA
Tufts Medical Center
Phase 4 Completed
NCT01295151 2016-11-02
SWITCH
University of Leeds
Phase 4 Completed
NCT02878161 2016-08-25
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
Central South University
Phase 4 Unknown
NCT01283971 2014-02-10
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor
Hoffmann-La Roche
Phase 4 Terminated
NCT00696059 2008-06-12
HURRAH
Hvidovre University Hospital
Phase 4 Completed